303 related articles for article (PubMed ID: 36334414)
1. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein.
Nuovo GJ; Magro C; Shaffer T; Awad H; Suster D; Mikhail S; He B; Michaille JJ; Liechty B; Tili E
Ann Diagn Pathol; 2021 Apr; 51():151682. PubMed ID: 33360731
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Aβ
Hsu JT; Tien CF; Yu GY; Shen S; Lee YH; Hsu PC; Wang Y; Chao PK; Tsay HJ; Shie FS
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360989
[TBL] [Abstract][Full Text] [Related]
4. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
5. Histologic, viral, and molecular correlates of heart disease in fatal COVID-19.
Mezache L; Nuovo GJ; Suster D; Tili E; Awad H; Radwański PB; Veeraraghavan R
Ann Diagn Pathol; 2022 Oct; 60():151983. PubMed ID: 35660807
[TBL] [Abstract][Full Text] [Related]
6. Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein.
Romero MJ; Yue Q; Singla B; Hamacher J; Sridhar S; Moseley AS; Song C; Mraheil MA; Fischer B; Zeitlinger M; Chakraborty T; Fulton D; Gan L; Annex BH; Csanyi G; Eaton DC; Lucas R
Front Immunol; 2023; 14():1241448. PubMed ID: 37638055
[TBL] [Abstract][Full Text] [Related]
7. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.
Ding Q; Shults NV; Gychka SG; Harris BT; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567524
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.
Perico L; Morigi M; Galbusera M; Pezzotta A; Gastoldi S; Imberti B; Perna A; Ruggenenti P; Donadelli R; Benigni A; Remuzzi G
Front Immunol; 2022; 13():827146. PubMed ID: 35320941
[TBL] [Abstract][Full Text] [Related]
9. Severe COVID-19: A multifaceted viral vasculopathy syndrome.
Magro CM; Mulvey J; Kubiak J; Mikhail S; Suster D; Crowson AN; Laurence J; Nuovo G
Ann Diagn Pathol; 2021 Feb; 50():151645. PubMed ID: 33248385
[TBL] [Abstract][Full Text] [Related]
10. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
12. A Standardization Protocol for the In Situ Detection of SARS-CoV2 RNA and Proteins.
Nuovo GJ; Suster D; Tili E; Awad H; Magro C
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):83-90. PubMed ID: 35175238
[TBL] [Abstract][Full Text] [Related]
13. The histologic and molecular correlates of liver disease in fatal COVID-19 including with alcohol use disorder.
Nuovo GJ; Suster D; Awad H; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Apr; 57():151881. PubMed ID: 34968863
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
Basu A; Sarkar A; Maulik U
Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836
[TBL] [Abstract][Full Text] [Related]
18. The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get?
Nugent MA
Cells; 2022 Mar; 11(5):. PubMed ID: 35269476
[TBL] [Abstract][Full Text] [Related]
19. The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders.
Ayyubova G; Gychka SG; Nikolaienko SI; Alghenaim FA; Teramoto T; Shults NV; Suzuki YJ
Life (Basel); 2024 Feb; 14(2):. PubMed ID: 38398788
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID.
Clough E; Inigo J; Chandra D; Chaves L; Reynolds JL; Aalinkeel R; Schwartz SA; Khmaladze A; Mahajan SD
J Neuroimmune Pharmacol; 2021 Dec; 16(4):770-784. PubMed ID: 34599743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
